Compare Summit Therapeutics Inc (SMMT) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Nuscale Power Corporation — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Nuscale Power Corporation trades at $8.83 (market cap $2.76B). The key difference: Summit Therapeutics Inc is far larger — about 3.8× Nuscale Power Corporation's market cap. Which is the better fit depends on your goals.
| SMMT | SMR | |
|---|---|---|
Market Cap | $10.48B | $2.76B |
Sector | Health | Utilities |
52-Week High | $29.32 | $53.43 |
52-Week Low | $13.05 | $7.64 |
Enterprise Value | $9.90B | $1.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
